Average Co-Inventor Count = 9.76
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (16 from 3,685 patents)
2. The Scripps Research Institute (3 from 1,187 patents)
3. Viiv Healthcare UK (no. 4) Limited (1 from 8 patents)
4. Viiv Healthcare UK Limited (9 patents)
17 patents:
1. 12492217 - Reagents and their use for modular enantiodivergent synthesis of C—P bonds
2. 12077558 - Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds
3. 12018097 - Non-chromatographic purification of macrocyclic peptides by a resin catch and release
4. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds
5. 11479581 - Non-chromatographic purification of macrocyclic peptides by a resin catch and release
6. 11254679 - Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide
7. 10221208 - Methods of producing an HIV maturation inhibitor
8. 10106560 - Process and intermediates for making tubulysin analogs
9. 9518058 - Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide
10. 9403821 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
11. 9394322 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
12. 9376458 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
13. 9273067 - Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
14. 9255113 - Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound
15. 9249168 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound